International Active Surveillance Study of Medication Used for the Treatment of Endometriosis: Visanne Post-approval Observational Study.

Trial Profile

International Active Surveillance Study of Medication Used for the Treatment of Endometriosis: Visanne Post-approval Observational Study.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2018

At a glance

  • Drugs Dienogest (Primary) ; Hormones
  • Indications Endometriosis
  • Focus Adverse reactions
  • Acronyms VIPOS
  • Most Recent Events

    • 24 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2019.
    • 24 Jan 2018 Planned primary completion date changed from 1 Jun 2017 to 1 Jul 2018.
    • 30 Aug 2017 Results comparing safety and drug utilisation patterns of dienogest with other hormonal treatments, presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top